Interesting comments when he is presenting at the Nash Conference for Leronlimab’s Nash phase 1 efficacy and safety. He must believe that one of the two drugs is Leronlimab and maybe we find out what other drug he believes will be co-administrated to treat Nash. I can get on board with being one of two drugs to treat a trillion dollar indication.

His Twitter reply…


Mazen Noureddin, MD, MHSc
@NoureddinMD
·
Apr 21
Thank you
@senthilsundaram
. It means Having more than one medication to treat the disease